GLSI Stock Analysis: Buy, Sell, or Hold?
GLSI - Greenwich LifeSciences, Inc.
$30.07
0.05 (0.17%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
23d
Get Alerted When GLSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
28 traders called GLSI this week
98% bullish • 1 bearish
98% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: GLSI is 11.5% above fair value ($26.98). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: GLSI is 11.5% above fair value ($26.98). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: GLSI is currently trading at $30.07, which is considered extended relative to its 30-day fair value range of $17.19 to $26.98.
Technical Outlook: Technically, GLSI is in a strong uptrend. Immediate support is located at $20.00, while resistance sits at $34.10.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $47.50 (+58.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLSI is in a strong uptrend. Immediate support is located at $20.00, while resistance sits at $34.10.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $47.50 (+58.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$17.19 -
$26.98
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
Protect Your Profits
Holding GLSI? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+11.5% above fair value)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 58.0% below Wall St target ($47.50)
Fair Price Analysis
30-Day Fair Range
$17.19 -
$26.98
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$20.00
Resistance Level
$34.10
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-22.11
Wall Street Target
$47.50
(+58.0%)
Last updated: February 01, 2026 5:55 AM ET
Data refreshes hourly during market hours. Next update: 6:55 AM
Data refreshes hourly during market hours. Next update: 6:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced GLSI Option Strategies
Professional options setups generated by AI based on today's GLSI price and gamma walls.
